Pharmacy
School of Pharmacy
- Location
- Belfast, United Kingdom
- Funding
- See university guidance
- Application deadline
- See university guidance
About the project
Prof. Al-Jamal’s team focuses on advanced nanotherapeutics. She has a multidisciplinary team working on developing innovative nanomedicines for combinatory therapy and theranostic applications.
To design and develop smart (stimuli-responsive) vectors to improve biologics and conventional anticancer therapy, besides introducing new targeting approaches to enhance efficacy and reduce the side effects of existing therapeutics and treatments.
Explore new methodologies, such as microfluidics, to fabricate and scale up multifunctional and lipid nanoparticles for combinatory therapy, immunotherapy, or theranostic applications.
- Prof Wafa Al-Jamal: School of Pharmacy
Contact info
- View Academic Profile
- w.al-jamal@qub.ac.uk
- +44(0)2890972609
- @aljamalwafa
Research Interests
Open to PhD applications in the field of:
Make a PhD enquiry
- Biologics
- Immunotherapy
- Tumour microenvironment
- Non-thermal electroporation
- Targeted delivery/Theranostics
- Smart and novel nanomaterials
- Prostate and pancreatic cancer
Public outreach & key achievements
- Prostate Cancer Photos Competition 2019
- Developing new nanomedicine for advanced prostate cancer
- GSK Emerging Scientist Award for nanomedicine research
- Nanomedicine: promises and challenges for the future of public health
Research students
PhD Title | Fucoidan-based Nanoparticles for Drug Delivery System to Enhance Cancer Immunotherapy
Name | Ms Ungsari Rizki Eka Purwanto
Years of Study | 2024 - 2028
Country | Republic of Indonesia
PhD Title | Molecularly Imprinted Nanocarriers for Cancer Immunotherapy
Name | Ms Minao Zhang
Years of Study | 2022 - 2025
Country | China
PhD Title | Developing mRNA-Nanomedicines to Potentiate Immunotherapy in Pancreatic Cancer
Name | Ms Raghad Qadadeh
Years of Study | 2022 - 2025
Country | Jordan
Alumni: Where are they now
PhD Title | Preparation of multifunctional nanoparticles using microfluidics
Name | Dr Calvin Cheung
Years of Study | 2016 - 2020
Country | Hong Kong
Current Position | Senior Technical Officer, The University of Hong Kong, Hong Kong
PhD Title | Developing a thermoresponsive targeted nanomedicine for advanced prostate cancer
Name | Dr Sara Pereira
Years of Study | 2014 - 2019 (part-time)
Country | Portugal
Current Position | Senior Scientist, AstraZeneca, Cambridge, UK
PhD Title | Development of Novel Cupric- Tirapazamine Liposomes for Hypoxia Selective Therapy
Name | Dr Vera Silva
Years of Study | 2014 - 2017
Country | Portugal
Current Position | Oncology Scientist at Engitix Therapeutics, UK